You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
Cofactor Genomics announced it raised $1.17 Million in an initial filing from an offering of $2 Million
PRIVATEAug 02, 2023•about 3 years ago
Amount Raised
$1.17 Million
Round Type
Seed
St. LouisBiotechnology
Company Information
Company
COFACTOR GENOMICS, INC.
Location
4044 CLAYTON AVENUE
St. Louis, Missouri, United States
About
Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment COFACTOR GENOMICS, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
St. LouisBiotechnology